Sunnybrook Research Institute
Dr. Swardfager is an Assistant Professor of Pharmacology & Toxicology at the University of Toronto, and a Scientist in the Hurvitz Brain Sciences Program at Sunnybrook Research Institute. He holds a Tier 2 Canada Research Chair in the clinical pharmacology of cognitive neurovascular disorders.
Dr. Swardfager’s lab focuses on understanding how disease and dysfunction of the cerebral small vessels contributes to mood and cognitive decline and the risk of Alzheimer’s disease and other dementias. He leads a team grant from the Canadian Institutes of Health Research to accelerate the discovery of effective anti-inflammatory strategies to counter cerebral small vessel disease. Additionally, he is the Principal Investigator of the Sunnybrook Type 2 Diabetes Study, which aims to understand the roles of biological and psychosocial factors in cognitive longevity.
Dr. Swardfager and his trainees have authored over 120 peer-reviewed publications which have accrued over 10,000 citations.